Kanabo Group (GB:KNB) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Kanabo Group, an innovator in digital health and specialized medicines, reported a significant 55% revenue increase in the first half of 2024, driven by the expansion of their Treat-It clinic franchise and advancements in AI and e-prescription technologies. The company, which focuses on telehealth platforms and cannabis-based treatments, is poised for further growth with confidence in their strategic plan and upcoming product launches. Amidst these developments, Kanabo remains committed to enhancing patient access to healthcare and operational efficiency.
For further insights into GB:KNB stock, check out TipRanks’ Stock Analysis page.
